Reaction Details |
| Report a problem with these data |
Target | Somatostatin receptor type 4 |
---|
Ligand | BDBM523770 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2223692 (CHEMBL5137205) |
---|
Ki | 0.700000±n/a nM |
---|
Citation | Neumann, WL; Sandoval, KE; Mobayen, S; Minaeian, M; Kukielski, SG; Srabony, KN; Frare, R; Slater, O; Farr, SA; Niehoff, ML; Hospital, A; Kontoyianni, M; Crider, AM; Witt, KA Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment. RSC Med Chem12:1352-1365 (2021) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Somatostatin receptor type 4 |
---|
Name: | Somatostatin receptor type 4 |
Synonyms: | SOMATOSTATIN SST4 | SS-4-R | SS4-R | SS4R | SSR4_HUMAN | SST4R | SSTR4 | Somatostatin receptor type 4 (SSTR4) |
Type: | Enzyme |
Mol. Mass.: | 42015.38 |
Organism: | Homo sapiens (Human) |
Description: | P31391 |
Residue: | 388 |
Sequence: | MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLV
GLVGNALVIFVILRYAKMKTATNIYLLNLAVADELFMLSVPFVASSAALRHWPFGSVLCR
AVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRAATYRRPSVAKLINLGVWLASLLVTLP
IAIFADTRPARGGQAVACNLQWPHPAWSAVFVVYTFLLGFLLPVLAIGLCYLLIVGKMRA
VALRAGWQQRRRSEKKITRLVLMVVVVFVLCWMPFYVVQLLNLFVTSLDATVNHVSLILS
YANSCANPILYGFLSDNFRRFFQRVLCLRCCLLEGAGGAEEEPLDYYATALKSKGGAGCM
CPPLPCQQEALQPEPGRKRIPLTRTTTF
|
|
|
BDBM523770 |
---|
n/a |
---|
Name | BDBM523770 |
Synonyms: | US11136312, Compound SK-I-124 |
Type | Small organic molecule |
Emp. Form. | C26H23F2N7 |
Mol. Mass. | 471.5045 |
SMILES | Fc1ccc2c(Cc3nnc(Cc4c[nH]c5cc(F)ccc45)n3CCCc3c[nH]cn3)c[nH]c2c1 |
Structure |
|